Report #2864915

Received Oct 10, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 27 yrs
State: —
Recovered: Unknown
Vaccinated: Oct 3, 2025
Onset: Oct 3, 2025
Days to onset: 0
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
RSV	RSV (AREXVY)	GLAXOSMITHKLINE BIOLOGICALS	UNK	—	IM

Symptoms (2)

Exposure during pregnancyProduct use issue

Symptom narrative

Patient presented to pharmacy for RSV vaccine. It 34 weeks pregnant. Pharmacist looked up guidelines for RSV vaccine and confirmed it can be administered between 32-36 weeks, but did not realize that only Abrysvo is indicated in pregnancy (NOT Arexvy). Pharmacy only stocks Arexvy. Patient received a dose. 3 days later, pharmacist realized the error. Contacted patient and patient's OB/Gyn . Patient is being monitored but no noted signs of adverse events. Prior to vaccination, patient was already scheduled for an induction at 37 weeks.